Summary workshop report: Biopharmaceutics classification system—implementation challenges and extension opportunities by Polli, James E., Yu, Lawrence X., Cook, Jack A., Amidon, Gordon L., Borchardt, Ronald T., Burnside, Beth A., Burton, Philip S., Chen, Mei‐Ling, Conner, Dale P., Faustino, Patrick J., Hawi, Amale A., Hussain, Ajaz S., Joshi, Hemant N., Kwei, Gloria, Lee, Vincent H.L., Lesko, Lawrence J., Lipper, Robert A., Loper, Alice E., Nerurkar, Shriniwas G., Polli, Joseph W., Sanvordeker, Dilip R., Taneja, Rajneesh, Uppoor, Ramana S., Vattikonda, Chandra S., Wilding, Ian, Zhang, Guohua

Get full text

Lymphatic uptake of MK-386, a sterol 5 α-reductase inhibitor, from aqueous and lipid formulations by Kwei, Gloria Y, Novak, Linda B, Hettrick, Lisa H, Reiss, Elisabeth R, Fong, Eva K, Olah, Timothy V, Loper, Alice E

Get full text

Routes of exposure: Topical and transdermal by Cukierski, Matthew J., Loper, Alice E.

Get full text

Identification of oxidative degradates of the thrombin inhibitor, 3-(2-phenethylamino)-6-methyl-1-(2-amino-6-methyl-5-methylenecarboxamidomethylpyridinyl)pyrazinone, using liquid c... by Wu, Yunhui, Chen, Xin, Gier, Lynn, Almarsson, Örn, Ostovic, Drazen, Loper, Alice E.

Get full text

Regiospecific intestinal absorption of the HIV protease inhibitor L-735,524 in beagle dogs by KWEI, G. Y, NOVAK, L. B, HETTRICK, L. A, REISS, E. R, OSTOVIC, D, LOPER, A. E, LUI, C. Y, HIGGINS, R. J, I-WU CHEN, LIN, J. H

Get full text

The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect o... by Wu, Yunhui, Loper, Alice, Landis, Elizabeth, Hettrick, Lisa, Novak, Linda, Lynn, Kari, Chen, Cindy, Thompson, Karen, Higgins, Ray, Batra, Udit, Shelukar, Suhas, Kwei, Gloria, Storey, David

Get full text